Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer-Reference-Cited by-同舟云学术

Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer

Published:2020-06-16 Issue:2 Volume:20 Page:1649-1656
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Kong De-Di¹,Fu Rong-Zhan¹,Li Liang²,Wang Wei³,Wang Shi-Bing³

Affiliation:

1. Department of Thyroid and Breast Surgery, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, P.R. China

2. Department of Pathology, Jining No.1 People's Hospital, Jining, Shandong 272011, P.R. China

3. Department of Thyroid and Breast Surgery, Jining No.1 People's Hospital, Jining, Shandong 272011, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-08-18

2. Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis;Systematic Reviews;2024-04-04

3. Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: A systematic review and meta-analysis;2023-11-28

4. Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review;International Journal of Molecular Sciences;2023-02-03

5. Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC;International Journal of Molecular Sciences;2022-01-31